Paul B. Miller

ORCID: 0000-0002-3766-6223 · 11 papers in corpus
2023
·doi:10.1016/j.fertnstert.2023.08.206
other 2019
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-018-1388-x

PURPOSE: To evaluate the effect of medical or surgical treatment prior to embryo transfer in women with elevated endometrial BCL6 expression and suspected endometriosis in a prospective, cohort study design at a university-associated infert…

observational 2019
Human reproduction open ·doi:10.1093/hropen/hoz021

STUDY QUESTION: Is B-cell CLL/lymphoma 6 (BCL6) endometrial expression, a surrogate biomarker of endometriosis, elevated in women with unexplained recurrent pregnancy loss (uRPL) and unexplained infertility (UI) compared to fertile subjects…

observational 2017
Fertility and sterility ·doi:10.1016/j.fertnstert.2017.09.017

OBJECTIVE: To evaluate endometrial BCL6 expression as a prognostic biomarker for IVF outcome in women with unexplained infertility (UI) before ET. DESIGN: Prospective cohort study. SETTING: University-associated infertility clinic. PATIE…

observational 2014
·doi:10.5301/je.5000181

Purpose The aim of this study was to investigate if there is a higher incidence of endometriosis in patients with polycystic ovary syndrome (PCOS), compared with normal fertile controls. Material and methods Women with PCOS according to Rot…

other 2012
Human reproduction (Oxford, England) ·doi:10.1093/humrep/der452

BACKGROUND: Our aim was to study ways to improve IVF success rates in women with suspected endometrial receptivity defects. METHODS: We conducted a retrospective cohort study examining the effect of letrozole (aromatase inhibitor) on integ…

2011
·doi:10.1016/j.fertnstert.2011.07.518
2011
·doi:10.1016/j.fertnstert.2011.07.1052
2010
·doi:10.1016/j.fertnstert.2010.07.332
2010
·doi:10.1016/j.fertnstert.2010.07.145
2007
·doi:10.1016/j.fertnstert.2007.07.205